Fig. 3From: Prognostic significance of cyclin D3 expression in malignancy patients: a meta-analysisResults of subgroup analysis of pooled HR of OS for malignancy patients. a Subgroup analysis stratified by sample size. b Subgroup analysis stratified by type of cancer. c Subgroup analysis stratified by follow-up time. d Subgroup analysis stratified by NOS score. e Subgroup analysis stratified by source of HRBack to article page